You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Acarbose - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for acarbose and what is the scope of patent protection?

Acarbose is the generic ingredient in two branded drugs marketed by Avet Lifesciences, Dash Pharms, Hangzhou Zhongmei, Hikma, Impax Labs, Strides Pharma, Virtus Pharm, Watson Labs, and Bayer Hlthcare, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for acarbose. Ten suppliers are listed for this compound.

Summary for acarbose
Drug Prices for acarbose

See drug prices for acarbose

Recent Clinical Trials for acarbose

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Empros Pharma ABPhase 1
CTC Clinical Trial Consultants ABPhase 1
University Teaching Hospital, Lusaka, ZambiaPhase 3

See all acarbose clinical trials

Pharmacology for acarbose
Medical Subject Heading (MeSH) Categories for acarbose
Paragraph IV (Patent) Challenges for ACARBOSE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
PRECOSE Tablets acarbose 25 mg, 50 mg and 100 mg 020482 1 2005-03-22

US Patents and Regulatory Information for acarbose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs ACARBOSE acarbose TABLET;ORAL 078441-002 May 14, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma ACARBOSE acarbose TABLET;ORAL 090912-001 Jul 27, 2011 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs ACARBOSE acarbose TABLET;ORAL 077532-002 May 7, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hangzhou Zhongmei ACARBOSE acarbose TABLET;ORAL 213821-003 Aug 18, 2020 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for acarbose

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-004 May 29, 1997 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-002 Sep 6, 1995 ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-001 Sep 6, 1995 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.